Sana Biotechnology Inc.
SANA | NASDAQ
$3.17
+$0.07 (+2.26%)
Sep 22, 2026, 2:43 PM ET · Market open
Market Data
Market Cap $862.7M
Enterprise Value $775.95M
Beta 2.13
Average Volume 3.3M
Shares Outstanding (Diluted) 295.67M
Shares Change YoY 24.02%
Institutional Ownership 59.32%
Exchange NASDAQ
ISIN US7995661045
Price Performance
Price Change 1M -20.1%
Price Change 3M -7.5%
Price Change 6M 0.0%
Price Change YTD -26.0%
Price Change 1Y -4.6%
Price Change 3Y -19.1%
Price Change 5Y -85.7%
1M CAGR (ann.) -11.9%
1Y CAGR (ann.) -5.8%
5Y CAGR (ann.) -34.0%
All-Time CAGR -35.0%
Valuation
PE Ratio -4.13
Forward PE N/A
PEG Ratio -0.12
Forward PEG 0.30
PS Ratio N/A
Forward PS 124.10
PB Ratio 5.58
P/FCF Ratio -6.39
P/Adj. FCF Ratio -5.46
P/OCF Ratio -6.89
EV/Sales N/A
EV/EBIT -3.66
EV/EBITDA -3.86
EV/FCF -5.75
Earnings Yield -24.2%
FCF Yield -15.7%
Adj. FCF Yield -18.3%
Financial Health
Net Cash $160.49M
Total Debt $73.74M
Cash & Short-Term Investments $160.49M
Total Assets $431.52M
Current Ratio 1.38
Quick Ratio 1.38
Debt / Equity Ratio 0.48
Debt / EBITDA -0.37
Debt / FCF -0.55
OCF / Debt -1.79
Interest Coverage 0.00
Altman Z-Score -5.98
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -16.9%
Returns
Return on Assets -49.1%
Return on Equity -134.5%
Return on Invested Capital -64.5%
Return on Capital Employed -67.6%
Return on Tangible Assets -91.4%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 20.3%
EPS CAGR 5Y 19.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y 37.1%
FCF CAGR 5Y 20.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y 2.2%
Revenue Growth Next 3Y N/A
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.18
EPS Growth Est (next Q) 20.0%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7
Price Target Upside 125.8%
Cash Flow
Operating Cash Flow $-132.24M
Free Cash Flow $-135.06M
Adj. Free Cash Flow $-157.88M
FCF Per Share -$0.46
OCF Per Share -$0.45
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-2.39M
Operating Income $-208M
EBITDA $-200.99M
Net Income $-211.82M
EPS (Diluted) -$0.75
Revenue / Employee N/A
Profit / Employee $-1.49M
Employees 142
Add to Watchlist
Select watchlists to add or remove SANA